Cargando…

Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients

Detalles Bibliográficos
Autores principales:	Herrera, Mercedes, Berral-González, Alberto, López-Cade, Igor, Galindo-Pumariño, Cristina, Bueno-Fortes, Santiago, Martín-Merino, Manuel, Carrato, Alfredo, Ocaña, Alberto, De La Pinta, Carolina, López-Alfonso, Ana, Peña, Cristina, García-Barberán, Vanesa, De Las Rivas, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082938/ https://www.ncbi.nlm.nih.gov/pubmed/33926453 http://dx.doi.org/10.1186/s12943-021-01367-x

Ejemplares similares

A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy
por: Herrera, Mercedes, et al.
Publicado: (2019)

Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity Correlations
por: Arroyo, Monica M., et al.
Publicado: (2020)

Endothelial cell activation on 3D-matrices derived from PDGF-BB-stimulated fibroblasts is mediated by Snail1
por: Herrera, Alberto, et al.
Publicado: (2018)

Identification of a gene expression signature associated with breast cancer survival and risk that improves clinical genomic platforms
por: Bueno-Fortes, Santiago, et al.
Publicado: (2023)

Radiogenomics: Hunting Down Liver Metastasis in Colorectal Cancer Patients
por: de la Pinta, Carolina, et al.
Publicado: (2021)

Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients’ Outcome
por: Galindo-Pumariño, Cristina, et al.
Publicado: (2021)

Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer
por: Herrera, Mercedes, et al.
Publicado: (2018)

Genomic mapping of copy number variations influencing immune response in breast cancer
por: López-Cade, Igor, et al.
Publicado: (2022)

Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling
por: Martinez-Romero, Jorge, et al.
Publicado: (2018)

Comparative Analysis of Cell Mixtures Deconvolution and Gene Signatures Generated for Blood, Immune and Cancer Cells
por: Alonso-Moreda, Natalia, et al.
Publicado: (2023)

A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer
por: Bueno-Fortes, Santiago, et al.
Publicado: (2021)

Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer
por: Noblejas-López, María del Mar, et al.
Publicado: (2021)

Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast Cancer
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2021)

Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer
por: Rodríguez, Marta, et al.
Publicado: (2015)

The Diet as a Modulator of Tumor Microenvironment in Colorectal Cancer Patients
por: Collado, Manuel, et al.
Publicado: (2023)

Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2023)

Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer
por: Saiz-Ladera, Cristina, et al.
Publicado: (2021)

Combining dissimilarity based classifiers for cancer prediction using gene expression profiles
por: Blanco, Ángela, et al.
Publicado: (2007)

BET inhibitors as novel therapeutic agents in breast cancer
por: Ocaña, Alberto, et al.
Publicado: (2017)

Combining Dissimilarities in a Hyper Reproducing Kernel Hilbert Space for Complex Human Cancer Prediction
por: Martín-Merino, Manuel, et al.
Publicado: (2009)

Bioactive compounds produced by gut microbial tannase: implications for colorectal cancer development
por: López de Felipe, Félix, et al.
Publicado: (2014)

Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
por: Ferrer-Mayorga, Gemma, et al.
Publicado: (2017)

Neutrophils in cancer: prognostic role and therapeutic strategies
por: Ocana, Alberto, et al.
Publicado: (2017)

A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants
por: Earl, Julie, et al.
Publicado: (2020)

Clinical considerations for the design of PROTACs in cancer
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2022)

Case report: Clinical success targeting BRAF-mutated, hormone receptor positive, HER2- negative advanced breast cancer patient with BRAF-inhibitor plus MEK- inhibitor
por: López de Sá, Alfonso, et al.
Publicado: (2022)

Interactome Data and Databases: Different Types of Protein Interaction
por: De Las Rivas, Javier, et al.
Publicado: (2004)

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2016)

A robust estimation of exon expression to identify alternative spliced genes applied to human tissues and cancer samples
por: Risueño, Alberto, et al.
Publicado: (2014)

Mapping Bromodomains in breast cancer and association with clinical outcome
por: Pérez-Pena, Javier, et al.
Publicado: (2019)

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer
por: Corrales‐Sánchez, Verónica, et al.
Publicado: (2020)

Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles
por: Juan, Alberto, et al.
Publicado: (2022)

Quercetin supplementation promotes recovery after exercise-induced muscle damage: a systematic review and meta-analysis of randomized controlled trials
por: Rojano-Ortega, Daniel, et al.
Publicado: (2022)

Personalized therapies in the cancer "omics" era
por: Ocaña, Alberto, et al.
Publicado: (2010)

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
por: Pérez-Pena, Javier, et al.
Publicado: (2019)

Uncovering therapeutic opportunities in the clinical development of antibody‐drug conjugates
por: Nieto‐Jiménez, Cristina, et al.
Publicado: (2023)

Proteolysis targeting chimeras (PROTACs) in cancer therapy
por: Ocaña, Alberto, et al.
Publicado: (2020)

Radiomics in lung cancer for oncologists
por: de la Pinta, Carolina, et al.
Publicado: (2020)

Seguridad en la selección del tratamiento antibiótico oral en las infecciones comunitarias, más allá de la COVID-19
por: Barberán, José, et al.
Publicado: (2021)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9evpk514ndrcvk819bv7ln4j1